Hippo (HIPOW) Form 144: 5,177 RSU Shares Proposed Sale ($192.6K)

Hippo Holdings Inc. (HIPOW) submitted a Form 144 disclosing a proposed sale of 5,177 common shares by a person for whose account the securities are to be sold.

Rhea-AI Filing Summary

Hippo Holdings Inc. (HIPOW) submitted a Form 144 disclosing a proposed sale of 5,177 common shares by a person for whose account the securities are to be sold. The shares have an aggregate market value of $192,636.17 based on the filing, against 25,028,054 shares outstanding. The proposed approximate sale date is 09/17/2025 on the NYSE. The shares were acquired from the issuer as restricted stock units on 02/15/2025 and were paid in full on that date. The filer reports no securities sold in the past three months for the account.

Positive

• Filer provided full Rule 144 disclosure including acquisition details, market value, outstanding shares and intended sale date

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 disclosure of RSU sale; paperwork aligns with compliance expectations.

The filing documents a proposed sale under Rule 144 of 5,177 common shares acquired as restricted stock units from the issuer on 02/15/2025. The disclosure includes market value, outstanding share count and the intended exchange and sale date, which meets the standard public reporting and transparency requirements for an officer/affiliate sale under Rule 144. No prior sales in the past three months are reported, reducing aggregation concerns under the rule.

Equity Compensation Specialist

TL;DR: This appears to be a typical disposition of recently vested RSUs; size is small relative to total shares outstanding.

The 5,177 shares stem from RSUs granted and acquired through the issuer, with payment dated 02/15/2025. Given the aggregated outstanding shares reported, the proposed sale represents an immaterial percentage of the capital base, suggesting a limited potential market impact. The filing properly notes the origin and payment details, which is standard for compensatory equity dispositions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction does the HIPOW Form 144 disclose?

The filing discloses a proposed sale of 5,177 common shares with an aggregate market value of $192,636.17.

When were the shares acquired and how?

The shares were acquired on 02/15/2025 as restricted stock units from the issuer.

When is the proposed sale date and where will the sale occur?

The approximate date of sale is 09/17/2025 on the NYSE.

Does the filer report other sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

How many shares outstanding does the filing report?

The filing reports 25,028,054 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/17/2025 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002061058
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HIPPO HOLDINGS INC.
SEC File Number	001-39711
Address of Issuer	One Almaden Blvd., Suite 400 San Jose CALIFORNIA 95113
Phone	6502948463
Name of Person for Whose Account the Securities are To Be Sold	GUY ZELTSER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5177	192636.17	25028054	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2025	Restricted Stock Units	Issuer			5177	02/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 2/15/2025 through 5/15/2025
Date of Notice	09/17/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/18/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Guy Zeltser
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)